Scott Gottlieb

What Dr. Scott Gottlieb Thinks About The Heated Exchange Between Dr. Anthony Fauci and U.S. Sen. Rand Paul
Ex-FDA Commissioner Gottlieb On COVID-19: 'Things Will Be Normal In The Spring And Summer'
Airline, Cruise Stocks Sink As New COVID Strain Emerges In UK
Ex-FDA Commissioner Gottlieb On COVID-19: 'Things Will Be Normal In The Spring And Summer'
Airline, Cruise Stocks Sink As New COVID Strain Emerges In UK
Cramer: Wednesday A 'Monumental' Day In COVID-19 Battle
Pfizer CEO, Board Member On COVID-19 Vaccine Progress, 'Brief, But Hard Stretch' Ahead

Scott Gottlieb Recent News

Ex-FDA Commissioner On How Coronavirus Vaccine Approval Could Come In Stages
The Trump administration is urging individual states to start working on a strategy to distribute a coronavirus vaccine by Nov. 1, but some experts are skeptical of the quick timeline, as it comes just weeks after interim study results.
COVID-19 Update: Gottlieb On Vaccine Approval, GSK Exec Talks Antibody Drug
Media reports of the U.S. Food and Drug Administration looking to approve a coronavirus vaccine prior to the completion of clinical trials appear to be taken out of context, former FDA Commissioner Dr.
Plasma Treatment For COVID-19 Unlikely To Be 'Home Run,' Says Ex-FDA Commissioner
The FDA granted emergency authorization of convalescent plasma to treat hospitalized COVID-19 patients on Sunday, and this could be helpful in treatin
Ex-FDA Commissioner Analyzes Johnson & Johnson's Mega Vaccine Trial
Johnson & Johnson (NYSE: JNJ) plans on enrolling up to 60,000 people in a coronavirus vaccine trial, likely as part of a global development and regulatory approval strategy, ex-FDA Commissioner Scott Gottlieb said Friday on
3 Takes On Russia's Speedy Coronavirus Vaccine Development
Global stock markets jumped higher Tuesday morning after Russia became the first country to confirm that a coronavirus vaccine is safe for immediate use. Russia named its vaccine the "Sputnik V" in a reference to the cold war era, when the country was first to launch an artificial Earth satellite.
COVID-19 Vaccine Should Be Priced Similar To Flu Shot, Says Ex-FDA Commissioner
Therapeutic companies working on a COVID-19 vaccine could earn a profit on their product if it's priced similarly to a standard flu vaccine, former FDA commissioner and Pfizer Inc. (NYSE: PFE) board member Dr.
Ex-FDA Commissioner Gottlieb On Whether Coronavirus Vaccine Will Bring Return To Normal
Many investors are working under the assumption that a safe vaccine against the coronavirus will allow society to return to how it was pre-pandemic. Investors may be missing part of the story, including how the vaccines work, former FDA Commissioner Dr. Scott Gottlieb said on CNBC's "Squawk Box."
Novavax CEO Talks $1.6B Federal Funding Win, Ex-FDA Chief Says It's A 'Good Bet'
The U.S.
Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms'
The Trump administration is prioritizing five COVID-19 vaccine programs, but ex-FDA chief Dr. Scott Gottlieb said the White House needs to spread its bets.
Ex-FDA Chief Gottlieb Expects Coronavirus Therapeutic Option By Summer
Ex-FDA Chief Brushes Off Some Coronavirus Concerns As Investors Brace For Impact
Ex-FDA Chief: Juul Created Teen Vaping Epidemic
Bruce Linton On Vaping Regulations That Could Be 'Better For Public Safety'
Ex-FDA Chief Defends Return To Private Sector, Warren Calls For Resignation
Markets React Amid Report FDA Commish Scott Gottlieb Will Resign
FDA: CBD Products Mostly Illegal
FDA Warms To Considering Legal Cannabis Ingredients In Food
How Long Before The FDA Could Ban Menthol Cigarettes?
How The FDA May Be Overstepping Bounds With New E-Cigarette Policy
The Duel Over The JUUL: FDA Zeroes In On E-Cigarette Industry, Teen Use Concerns
FDA Says It Will Cut Nicotine In Cigarettes To 'Non-Addictive Levels'
Cowen Analyst Responds Following Amicus' Positive Migalastat News
What We Know About Trump's Potential Pick To Head The FDA

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved